Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-34,310
Closed -$664K 631
2017
Q4
$664K Buy
34,310
+1,065
+3% +$23.6K 0.01% 447
2017
Q3
$798K Sell
33,245
-760
-2% -$16.8K 0.02% 402
2017
Q2
$702K Sell
34,005
-900
-3% -$18K 0.02% 427
2017
Q1
$724K Sell
34,905
-2,260
-6% -$49K 0.02% 400
2016
Q4
$831K Buy
+37,165
New +$751K 0.02% 386
2015
Q4
Sell
-164,827
Closed -$2.41M 648
2015
Q3
$2.41M Buy
+164,827
New +$2.6M 0.09% 248

Other funds holding ADTN

Boston Advisors's ADTN Position: Q1 2018 in Review

Boston Advisors sold out of Adtran (ADTN) in Q1 2018, closing a stake of 34,310 shares — an estimated $664K sold.

Boston Advisors first reported a position in ADTN in Q3 2015 and held it in 6 quarters. The position peaked at $2.41M in Q3 2015. 158 funds tracked by Wall St. Rank hold ADTN as of Q1 2018.

  • Boston Advisors reported no remaining Adtran position as of Q1 2018 after selling out during the quarter.
  • Boston Advisors sold 34,310 Adtran shares in Q1 2018, an estimated $664K.
  • Boston Advisors first reported a position in Adtran in Q3 2015 and held it in 6 quarters.
  • Boston Advisors's Adtran position peaked at $2.41M in Q3 2015.
  • 158 funds tracked by Wall St. Rank held Adtran as of Q1 2018.

Based on Boston Advisors's 13F filing for Q1 2018, filed 25 Apr 2018.